Author

Michael Olson

Harvard UniversityORCID 0000-0002-1566-2029Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Michael Olson1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anthony G. LetaiiD· 1 shared Antonio J. AlmazaniD· 1 shared Brenda C. Chan· 1 shared Cheyanne Walker-WilliamsiD· 1 shared Cloud Peter PaweletziD· 1 shared Cole J. Turner· 1 shared Daryl GriffiniD· 1 shared David Allen BarbieiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony G. LetaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Death and DifferentiationPeer-reviewedDec 26, 2025

Drug tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms

Maria Davern, Cole J. Turner, Daryl Griffin…·Anthony G. Letai

This study identifies common survival mechanisms between drug-tolerant persisters and immunotherapy persisters, showing they share reduced mitochondrial apoptotic sensitivity and cross-resistance to therapies.

7 citations

humanproteomics

𝕏 PostBluesky